Suppr超能文献

[麻风分枝杆菌和结核分枝杆菌对新型喹诺酮耐药性获得的分子机制及耐药菌的快速鉴别方法]

[Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli].

作者信息

Kim Hyun, Suzuki Haruka, Matsuoka Masanori, Matsuba Takashi, Yokoyama Kazumasa, Nakajima Chie, Suzuki Yasuhiko

机构信息

Department of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Japan.

出版信息

Nihon Hansenbyo Gakkai Zasshi. 2011 Feb;80(1):17-27. doi: 10.5025/hansen.80.17.

Abstract

Drugs included in new-quinolone are used for the treatment of leprosy with single lesion. These drugs are also known to be effective drugs for the treatment of multi-drug resistant M. tuberculosis. Recent emergence of new-quinolone resistant M. leprae and M. tuberculosis enforced the urgent elucidation of the mode of emergence of new-quinolone resistant strains. In this review, new-quinolone drugs, their mode of action and mechanism of acquisition of resistance by M. leprae and M. tuberculosis were explained. And rapid differentiation methods for resistant bacilli were also introduced.

摘要

新型喹诺酮类药物可用于治疗单病灶麻风病。众所周知,这些药物也是治疗耐多药结核分枝杆菌的有效药物。最近出现的对新型喹诺酮耐药的麻风分枝杆菌和结核分枝杆菌,促使人们迫切需要阐明新型喹诺酮耐药菌株的出现方式。在这篇综述中,对新型喹诺酮类药物、其作用方式以及麻风分枝杆菌和结核分枝杆菌获得耐药性的机制进行了解释。同时还介绍了耐药杆菌的快速鉴别方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验